Together we are beating cancer

Donate now
  • Science & Technology
  • Health & Medicine

Can we grow the treatments of tomorrow? – That Cancer Conversation podcast

The Cancer Research UK logo
by Cancer Research UK | Podcast

2 September 2021

1 comment 1 comment

The logo of our podcast, That Cancer Conversation
This entry is part 2 of 14 in the series That Cancer Conversation

https://news.cancerresearchuk.org/2012/07/25/cannabis-cannabinoids-and-cancer-the-evidence-so-far/


From malaria to multiple sclerosis, plants have given us compounds which help treat countless conditions. But could a tree growing on your street hold the next life-changing drug?

From Madagascar to Kew Gardens in London, we explore how scientists across the globe use indigenous knowledge and pharmaceutical science to help develop the treatments of tomorrow.

And in a world-first, a cannabis-derived drug, known as Sativex, is being trialled in combination with chemotherapy to see if it could be used to help people with a certain type of aggressive brain cancer.

  • The botanical history of medicine (2:04)
  • How do we find the plant medicines of tomorrow? (6:10)
  • The search for a chemical needle in a botanical haystack (9:09)
  • Making drugs: converting cuttings into capsules (14:02)
  • Is it more complex than putting a leaf in a pill? (18:28)
  • Sativex: trialling a cannabis-derived spray on brain cancer (22:50)
  • Do we know how cannabinoids work on these cells? (26:51)
  • Cannabis and cancer: it’s not that simple (28:43)

ARISTOCRAT is a randomised phase II study of temozolomide with or without cannabinoids in patients with recurrent glioblastoma.

The trial is being funded by The Brain Tumour Charity and co-ordinated by the Cancer Research UK Clinical Trials Unit at the University of Birmingham.

ARISTOCRAT is due to begin recruiting just over 230 patients across all UK nations in early 2022.

To learn more about the ARISTOCRAT trial (as well as cannabis and cancer), you can check out:

If you’d like to talk to someone, our nurses are available Monday to Friday 9-5pm on freephone 0808 800 4040.

You can listen and subscribe for free on Apple Podcasts, Spotify or wherever you get your podcasts.

And if you have a question you’d like us to answer or topic you want us to explore, you can send an email to [email protected] and tell us about your idea!

    Comments

  • David Moore
    8 September 2021

    Surely such a research trial mustn’t use funds given to help Cancer patients!
    The excessive profits made by GM Pharmaceuticals that produce sativex must bear the costs for it and any patient involved?

    Comments

  • David Moore
    8 September 2021

    Surely such a research trial mustn’t use funds given to help Cancer patients!
    The excessive profits made by GM Pharmaceuticals that produce sativex must bear the costs for it and any patient involved?